| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |